BioCrude Technologies USA, Inc. Deferred Tax Assets, Net of Valuation Allowance
BioCrude Technologies USA, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-27 |